Automatic infusion system based on an adaptive patient model

Details Automatic infusion system based on an adaptive patient model Automatic infusion system based on an adaptive patient model

2003-03-24

2009-02-17

Lucchesi, Nicholas D. (Department: 3763)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S504000, C700S028000

Reexamination Certificate

active

07491187

ABSTRACT:
Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.

REFERENCES:
patent: 4055175 (1977-10-01), Clemens et al.
patent: 4280494 (1981-07-01), Cosgrove et al.
patent: 5971922 (1999-10-01), Arita et al.
patent: 6017318 (2000-01-01), Gauthier et al.
patent: 6544212 (2003-04-01), Galley et al.
patent: 6558351 (2003-05-01), Steil et al.
patent: 6572542 (2003-06-01), Houben et al.
patent: 6656114 (2003-12-01), Poulsen et al.
patent: 0 806 738 (1997-05-01), None
patent: 0806738 (1997-11-01), None
patent: WO 00/74753 (2000-12-01), None
patent: WO 01/83007 (2001-11-01), None
Bellazi et al., “The Subcutaneous Route to Insulin-Dependent Diabetes Therapy: Closed-Loop and Partially Closed-Loop Control Strategies for Insulin Delivery and Measuring Glucose Concentration,” IEEE Engineering in Medicine and Biology, 54-64 (Jan./Feb. 2001).
Parker et al., The Intravenous Route to Blood Glucose Control: A Review of Control Algorithms for Noninvasive Monitoring and Regulation in Type I Diabetic Patients, IEEE Engineering in Medicine and Biology, 65-73 (Jan./Feb. 2001 ).
Parker et al., “The Intravenous Route to Blood Glucose Control: A Review of Control Algorithms for Noninvasive Monitoring and Regulation in Type I Diabetic Patients,”IEEE Engineering in Medicine and Biology, 65-73 (Jan./Feb. 2001).
Van den Berghe et al., “Intensive Insulin Therapy in Critically Ill Patients,” The New England Journal of Medicine, 345(19): 1359-1367 (2001).
Communication from European Patent Office for European Patent Application No. EP 03 711 717.3 dated Sep. 18, 2008.

Affiliated with

Also associated with

Rating

Automatic infusion system based on an adaptive patient model does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Automatic infusion system based on an adaptive patient model, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Automatic infusion system based on an adaptive patient model will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4079876